Control integral de los factores de riesgo en pacientes de alto y muy alto riesgo cardiovascular en España: Estudio CIFARC
…, MM Rodríguez, A de la Peña Fernández… - Medicina …, 2005 - dialnet.unirioja.es
Fundamento y objetivo: El objetivo del presente estudio es determinar el porcentaje de
pacientes con alto riesgo cardiovascular que tienen controlados de forma global todos sus …
pacientes con alto riesgo cardiovascular que tienen controlados de forma global todos sus …
Association of hypertension with all-cause mortality among hospitalized patients with COVID-19
…, R Boixeda, A Pena-Fernandez… - Journal of clinical …, 2020 - mdpi.com
It is unclear to which extent the higher mortality associated with hypertension in the
coronavirus disease (COVID-19) is due to its increased prevalence among older patients or to …
coronavirus disease (COVID-19) is due to its increased prevalence among older patients or to …
Admission hyperglycaemia as a predictor of mortality in patients hospitalized with COVID-19 regardless of diabetes status: data from the Spanish SEMI-COVID-19 …
…, A de la Peña Fernández, JD Torres Peña… - Annals of …, 2021 - Taylor & Francis
Background Hyperglycaemia has emerged as an important risk factor for death in coronavirus
disease 2019 (COVID-19). The aim of this study was to evaluate the association between …
disease 2019 (COVID-19). The aim of this study was to evaluate the association between …
Control integral de los factores de riesgo en pacientes de alto y muy alto riesgo cardiovascular en España. Estudio CIFARC
A de la Peña Fernández, CS Fernández, IC Melero… - Medicina clínica, 2005 - Elsevier
Fundamento y objetivo El objetivo del presente estudio es determinar el porcentaje de
pacientes con alto riesgo cardiovascular que tienen controlados de forma global todos sus …
pacientes con alto riesgo cardiovascular que tienen controlados de forma global todos sus …
The importance of association of comorbidities on COVID-19 outcomes: a machine learning approach
…, J Fernández-Fernández… - Current Medical …, 2022 - Taylor & Francis
Background The individual influence of a variety of comorbidities on COVID-19 patient
outcomes has already been analyzed in previous works in an isolated way. We aim to determine …
outcomes has already been analyzed in previous works in an isolated way. We aim to determine …
Healthcare workers hospitalized due to COVID-19 have no higher risk of death than general population. Data from the Spanish SEMI-COVID-19 Registry
…, R Boixeda, R Gil Sanchez, A de la Pena Fernandez… - PLoS …, 2021 - journals.plos.org
Aim To determine whether healthcare workers (HCW) hospitalized in Spain due to COVID-19
have a worse prognosis than non-healthcare workers (NHCW). Methods Observational …
have a worse prognosis than non-healthcare workers (NHCW). Methods Observational …
The use of corticosteroids or tocilizumab in COVID-19 based on inflammatory markers
…, R Gil Sánchez, J Fernández Fernández… - Journal of General …, 2022 - Springer
Background The inflammatory cascade is the main cause of death in COVID-19 patients.
Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which …
Corticosteroids (CS) and tocilizumab (TCZ) are available to treat this escalation but which …
Integral control of risk factors in patients of high and very high cardiovascular risk in Spain. CIFARC project
A de la Peña Fernández, C Melero - Medicina Clinica, 2005 - europepmc.org
Results We studied 2,264 patients (53.7% males; mean age: 66.1+/-11.5 years; 74.6%
hypertensive, 61.1% dyslipidemic, 59.8% type 2 diabetes, 31.1% smokers, 38.0% obese and 36.7…
hypertensive, 61.1% dyslipidemic, 59.8% type 2 diabetes, 31.1% smokers, 38.0% obese and 36.7…
Disminución de hemorragias totales con dosis reducidas de enoxaparina en angina inestable de alto riesgo. Estudio ENHNFAI.(ENoxaparina vs Heparina No …
…, R Izaguirre Ávila, A Peña Fernández - … de cardiología de …, 2002 - scielo.org.mx
En este estudio prospectivo, aleatorizado y controlado, se compararon complicaciones en 2
grupos de tratamiento: Grupo 1, recibió enoxaparina 0.8 mg/kg subcutánea cada 12 horas …
grupos de tratamiento: Grupo 1, recibió enoxaparina 0.8 mg/kg subcutánea cada 12 horas …
Decreased total bleeding events with reduced doses of enoxaparin versus unfractionated heparin in high risk unstable angina
…, RI Ávila, A de la Peña Fernández - … de cardiología de …, 2002 - medigraphic.com
In this prospective, randomized and controlled study, we compare complications in 2 groups
of patients: group 1, enoxaparin 0.8 mg/kg, subcutaneous every 12 hours during 5 days, …
of patients: group 1, enoxaparin 0.8 mg/kg, subcutaneous every 12 hours during 5 days, …